Issue 8/2011
Content (33 Articles)
The influence of sex and puberty on the progression of diabetic nephropathy and retinopathy
J. N. Harvey
Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes
C. F. Bento, P. Pereira
The diabetic pregnancy and offspring BMI in childhood: a systematic review and meta-analysis
L. H. Philipps, S. Santhakumaran, C. Gale, E. Prior, K. M. Logan, M. J. Hyde, N. Modi
Disturbed subjective sleep characteristics in adult patients with long-standing type 1 diabetes mellitus
M. van Dijk, E. Donga, J. G. van Dijk, G. J. Lammers, K. W. van Kralingen, O. M. Dekkers, E. P. M. Corssmit, J. A. Romijn
Diabetic retinopathy in type 1 diabetes—a contemporary analysis of 8,784 patients
H. P. Hammes, W. Kerner, S. Hofer, O. Kordonouri, K. Raile, R. W. Holl
Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trial
J. E. Foley, M. C. Bunck, D. L. Möller-Goede, M. Poelma, G. Nijpels, E. M. Eekhoff, A. Schweizer, R. J. Heine, M. Diamant
Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes
V. Harjutsalo, C. Maric, C. Forsblom, L. Thorn, J. Wadén, P. H. Groop
Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
L. Govan, O. Wu, A. Briggs, H. M. Colhoun, J. A. McKnight, A. D. Morris, D. W. M. Pearson, J. R. Petrie, N. Sattar, S. H. Wild, R. S. Lindsay
No evidence of a higher 10 year period prevalence of diabetes among 77,885 twins compared with 215,264 singletons from the Danish birth cohorts 1910–1989
I. Petersen, M. M. F. Nielsen, H. Beck-Nielsen, K. Christensen
No evidence of an increased mortality risk associated with low levels of glycated haemoglobin in a non-diabetic UK population
R. Pfister, S. J. Sharp, R. Luben, K.-T. Khaw, N. J. Wareham
Polymorphisms in chromosome region 12q13 and their influence on age at onset of type 1 diabetes
L. Espino-Paisan, H. de la Calle, M. Fernández-Arquero, M. Á. Figueredo, E. G. de la Concha, E. Urcelay, J. L. Santiago
Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican-American sample from Starr County, Texas
E. J. Parra, J. E. Below, S. Krithika, A. Valladares, J. L. Barta, N. J. Cox, C. L. Hanis, N. Wacher, J. Garcia-Mena, P. Hu, M. D. Shriver, J. Kumate, P. M. McKeigue, J. Escobedo, M. Cruz
Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals
J. E. Below, E. R. Gamazon, J. V. Morrison, A. Konkashbaev, A. Pluzhnikov, P. M. McKeigue, E. J. Parra, S. C. Elbein, D. M. Hallman, D. L. Nicolae, G. I. Bell, M. Cruz, N. J. Cox, C. L. Hanis
mRNA of the pro-apoptotic gene BBC3 serves as a molecular marker for TNF-α-induced islet damage in humans
K. Omori, M. Mitsuhashi, K. Ishiyama, I. Nair, J. Rawson, I. Todorov, F. Kandeel, Y. Mullen
Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival
Z. Liu, V. Stanojevic, S. Avadhani, T. Yano, J. F. Habener
A novel role for vitamin D: modulation of expression and function of the local renin–angiotensin system in mouse pancreatic islets
Q. Cheng, Y. C. Li, B. J. Boucher, P. S. Leung
Adoptive cell therapy using antigen-specific CD4−CD8− T regulatory cells to prevent autoimmune diabetes and promote islet allograft survival in NOD mice
D. Zhang, W. Zhang, T. W. Ng, Y. Wang, Q. Liu, V. Gorantla, F. Lakkis, X. X. Zheng
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes
S. Camastra, A. Gastaldelli, A. Mari, S. Bonuccelli, G. Scartabelli, S. Frascerra, S. Baldi, M. Nannipieri, E. Rebelos, M. Anselmino, E. Muscelli, E. Ferrannini
Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial
D. H. van Raalte, M. Brands, N. J. van der Zijl, M. H. Muskiet, P. J. W. Pouwels, M. T. Ackermans, H. P. Sauerwein, M. J. Serlie, M. Diamant
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
M. E. Visser, N. M. Lammers, A. J. Nederveen, M. van der Graaf, A. Heerschap, M. T. Ackermans, H. P. Sauerwein, E. S. Stroes, M. J. Serlie
Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling
R. M. Holmes, Z. Yi, E. De Filippis, R. Berria, S. Shahani, P. Sathyanarayana, V. Sherman, K. Fujiwara, C. Meyer, C. Christ-Roberts, H. Hwang, J. Finlayson, L. Q. Dong, L. J. Mandarino, M. Bajaj
Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
F. W. Kiefer, S. Neschen, B. Pfau, B. Legerer, A. Neuhofer, M. Kahle, M. Hrabé de Angelis, M. Schlederer, M. Mair, L. Kenner, J. Plutzky, M. Zeyda, T. M. Stulnig
Susceptibility to diet-induced obesity and glucose intolerance in the APP SWE/PSEN1 A246E mouse model of Alzheimer’s disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein
N. Mody, A. Agouni, G. D. Mcilroy, B. Platt, M. Delibegovic
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
J. M. Luther, P. Luo, M. T. Kreger, M. Brissova, C. Dai, T. T. Whitfield, H. S. Kim, D. H. Wasserman, A. C. Powers, N. J. Brown
Short-term oxygen administration restores blunted baroreflex sensitivity in patients with type 1 diabetes
L. Bernardi, M. Rosengård-Bärlund, A. Sandelin, V. P. Mäkinen, C. Forsblom, P.-H. Groop
Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy
M. M. Jack, J. M. Ryals, D. E. Wright
Biliverdin protects against the deterioration of glucose tolerance in db/db mice
N. Ikeda, T. Inoguchi, N. Sonoda, M. Fujii, R. Takei, E. Hirata, H. Yokomizo, J. Zheng, Y. Maeda, K. Kobayashi, R. Takayanagi
Altered gap junctional communication and renal haemodynamics in Zucker fatty rat model of type 2 diabetes
T. Takenaka, T. Inoue, H. Okada, Y. Ohno, T. Miyazaki, D. J. Chaston, C. E. Hill, H. Suzuki
The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY
A. M. Steele, N. D. Tribble, R. Caswell, K. J. Wensley, A. T. Hattersley, A. L. Gloyn, S. Ellard
Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs
K. R. Hjøllund, C. F. Deacon, J. J. Holst
Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
Y. Miao, D. Dobre, H. J. Lambers Heerspink, B. M. Brenner, M. E. Cooper, H.-H. Parving, S. Shahinfar, D. Grobbee, D. de Zeeuw
Erratum to: The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up
H. K. Åkerblom